Increased expression of YTHDF1 and HNRNPA2B1 as potent biomarkers for melanoma: a systematic analysis

Table 2 P-values of different genes in five studies selected in Oncomine

	Critchley	Haqq	Riker	Talantov	TCGA
YTHDF1	0.187	–	–	–	1.14 * 10⁻⁷
ELF3	0.258	0.516	0.887	0.999	3.86 * 10⁻⁷
HNRNPA2B1	0.814	1.197	0.062	0.246	2.64 * 10⁻¹⁰
YTHDF2	0.117	0.392	0.182	0.020	0.441
WTAP	0.794	–	0.185	0.400	1.000
METTL14	0.671	–	0.899	–	0.962
FTO	0.167	0.035	0.259	0.818	0.989
ALKBH5	0.092	0.668	0.211	–	0.995
HNRNPC	0.200	–	0.322	2.68 * 10⁻⁵	0.943
METTL3	0.349	–	0.074	0.650	0.944

The results are from comparisons of patients with melanoma and healthy individuals. Critchley, Critchley-Thorne, et al., Plos Med (2007); Haqq, Christopher Haqq, et al., PNAS(2005); Riker, Adam I Riker, et al., BMC Med Genomics (2008); Talantov, Dmitri Talantov, et al., Human cancer biology (2005); TCGA, the cancer genome atlas (2013)

ISSN: 1475-2867